C B PHARMA ACQUISITION CORP's ticker is CNLMU and the CUSIP is G2029P100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,068,000 | +0.9% | 200,000 | 0.0% | 0.09% | -17.8% |
| Q4 2015 | $2,050,000 | -2.0% | 200,000 | 0.0% | 0.11% | -15.1% |
| Q3 2015 | $2,092,000 | -1.0% | 200,000 | 0.0% | 0.13% | +37.0% |
| Q2 2015 | $2,113,000 | +3.4% | 200,000 | 0.0% | 0.09% | -17.1% |
| Q1 2015 | $2,044,000 | -72.9% | 200,000 | -73.3% | 0.11% | -72.3% |
| Q4 2014 | $7,530,000 | – | 750,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENECA CAPITAL INVESTMENTS, L.P. | 150,000 | $1,533,000 | 0.35% |
| Polar Asset Management Partners Inc. | 200,000 | $2,044,000 | 0.11% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 350,000 | $3,577,000 | 0.08% |
| GLAZER CAPITAL, LLC | 39,524 | $404,000 | 0.06% |
| GOLDMAN SACHS GROUP INC | 19,400 | $198,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 28 | $0 | 0.00% |